Home › Free Stock Grades › ATRC
AtriCure, Inc. (ATRC) Stock Grade
ATRC · Healthcare
A+
Market Cap
$1.9B
P/E Ratio
—
Revenue Growth (YoY)
+14.9%
Net Margin
-2.1%
Return on Equity
—
Dividend Yield
None
About AtriCure, Inc.'s fundamentals
AtriCure is a $1.9 billion medical devices company experiencing solid revenue growth of 14.9% year-over-year, indicating expanding market demand for its products. However, the company currently operates at a net loss with a -2.1% net margin, meaning it spends more than it earns on an accounting basis. Despite this unprofitability, AtriCure generates positive free cash flow, suggesting its underlying operations produce cash even as accounting losses persist, which is not uncommon for growth-stage medical device companies investing heavily in expansion and development.